A detailed history of Lynch Asset Management, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Lynch Asset Management, Inc. holds 6,800 shares of MRK stock, worth $684,964. This represents 0.33% of its overall portfolio holdings.

Number of Shares
6,800
Previous 5,650 20.35%
Holding current value
$684,964
Previous $699,000 10.44%
% of portfolio
0.33%
Previous 0.3%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$111.15 - $128.97 $127,822 - $148,315
1,150 Added 20.35%
6,800 $772,000
Q3 2023

Oct 25, 2023

SELL
$102.95 - $114.33 $102,950 - $114,330
-1,000 Reduced 15.04%
5,650 $581,000
Q1 2023

Apr 20, 2023

SELL
$102.94 - $114.86 $51,470 - $57,430
-500 Reduced 6.99%
6,650 $707,000
Q4 2021

Feb 02, 2022

BUY
$72.28 - $90.54 $516,802 - $647,361
7,150 New
7,150 $549,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $255B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Lynch Asset Management, Inc. Portfolio

Follow Lynch Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lynch Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Lynch Asset Management, Inc. with notifications on news.